Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Appendectomy may be best for patients with positive CT exam

May 25, 2010 9:37 pm | by EurekAlert | News | Comments

(Radiological Society of North America) When CT results suggest appendicitis, but a patient's symptoms are inconsistent with the acute condition, physicians should consider a diagnosis of chronic or recurrent appendicitis and surgical treatment, according to a new study.

TOPICS:

Mobile access now available for Essential Evidence Plus

May 25, 2010 9:36 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) Global scientific, technical, medical and scholarly publisher Wiley-Blackwell today announced the that its evidence-based clinical decision support product, Essential Evidence Plus, is now accessible from mobile devices. Physicians on the move can now easily find...

TOPICS:

Medtronic's Q4 sales rise, earnings soar

May 25, 2010 1:38 pm | by Mass Device | News | Comments

Medtronic Inc. closed out fiscal 2010 on a high note, posting record Q4 sales of $4.2 billion and net earnings of $954 million; full-year profits near $3.1 billion on sales of $15.8 billion. Medtronic Inc. (NYSE: MDT) closed out fiscal 2010 in fine shape, posting record...

TOPICS:
Advertisement

MRI research highlights high-risk atherosclerotic plaque hidden in the vessel wall

May 25, 2010 1:37 pm | by EurekAlert | News | Comments

(Boston University Medical Center) Researchers from Boston University School of Medicine have shown that use of magnetic resonance imaging (MRI) in an animal model can noninvasively identify dangerous plaques. The findings, which appear in the May issue of Circulation...

TOPICS:

Springer launches Autoimmunity Highlights

May 25, 2010 1:37 pm | by EurekAlert | News | Comments

(Springer) Springer is launching a new journal titled Autoimmunity Highlights. It is an independent, international peer-reviewed journal that publishes papers related to the diverse aspects of autoimmunity and seeks to be a bridge between the clinic, the laboratory and the...

TOPICS:

Adolescents cope with mental illness stigmas, report CWRU researchers

May 25, 2010 1:37 pm | by EurekAlert | News | Comments

(Case Western Reserve University) Living with a mental illness can be a tough experience for adults, but with the increasing numbers of youth diagnosed and taking medications for mood disorders, it can become a time of isolation, according to a study from Case Western Reserve...

TOPICS:

Proton Pump Inhibitors (PPI): Class Labeling Change

May 25, 2010 1:35 pm | by U.S. Food & Drug Administration | News | Comments

Possible increased risk of fractures of the hip, wrist, and spine.

TOPICS:

Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.

May 25, 2010 12:36 pm | by Bio-Medicine.Org | News | Comments

ALLENTOWN, Pa. and CAMPBELL, Calif. , May 25 /- HunterHeart offers physicians and patients sophisticated risk characterization and personalized therapy guidelines for cardiovascular disease.  HNL will be performing a battery of advanced tests, offering an accompanying nutrition...

TOPICS:
Advertisement

Hanley Center Acquires the East Coast's First SPECT Scanner to Treat Addiction

May 25, 2010 12:36 pm | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla. , May 25 /- Hanley Center, one of the country's leading nonprofit addiction treatment centers, today announced plans to use SPECT (single photon emission computed tomography) scans to capture brain images of patients with alcohol and drug addiction. These pictures...

TOPICS:

Mylan Launches Temazepam Capsules USP, 7.5 mg

May 25, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH , May 25 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Temazepam Capsules USP, 7.5 mg. This additional strength, which had U.S. sales of approximately $56 million for the 12 months ending March 31, 2010 , according to...

TOPICS:

FDA Approves New Treatment for Late-Onset Pompe Disease

May 25, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md. , May 25 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder. (Logo:...

TOPICS:

Express Scripts spent $380,000 on lobbying in 1Q

May 25, 2010 9:10 am | by The Associated Press | News | Comments

Pharmacy benefits manager Express Scripts Inc. said it spent $380,000 in the first quarter as it lobbied Congress and federal agencies on issues related to health care reform, drug reimbursement and other issues.That's up from the $250,000 it spent on lobbying in the year-ago period and the...

T2 Biosystems raises $15 million Series C round

May 25, 2010 8:37 am | by Mass Device | News | Comments

T2 Biosystems Inc. raises $15 million in a Series C funding round to bring its benchtop MRI-based diagnostic device to market. T2 Biosystems Inc. raised about $15 million in a Series C funding round it plans to use to bring its benchtop MRI-based diagnostic device to...

TOPICS:

Summary Box: Medtronic 4th-quarter earnings

May 25, 2010 8:10 am | by The Associated Press | News | Comments

GAIN ON RIVAL'S PAIN: Medtronic said its fourth-quarter profit growth was helped by higher sales of implantable defibrillators after rival Boston Scientific suspended U.S. sales of those devices for a month.NET INCOME BOOST: Medtronic earned $954 million, or 86 cents per share, in the last quarter...

European Urology: Editorial about REDUCE trial underlines value of dutasteride

May 25, 2010 7:36 am | by EurekAlert | News | Comments

(European Association of Urology) On May 8, an editorial about the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial by Fritz H. Schröder and Monique J. Roobol was published in the online version of European Urology, the scientific journal of the European...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading